Abstract:Background: Rhodanines and quinazolinones have been reported to possess various pharmacological activities. Results: A novel series of twenty quinazolinone-based rhodanines were synthesized via Knoevenagel condensation between 4-[3-(substitutedphenyl)-3,4-dihydro-4-oxoquinazolin-2-yl)methoxy]substituted-benzaldehydes and rhodanine. Elemental and spectral analysis were used to confirm structures of the newly synthesized compounds. The newly synthesized compounds were biologically evaluated for in vitro cytotoxic activity against the human fibrosarcoma cell line HT-1080 as a preliminary screen using the MTT assay. Conclusions: All the target compounds were active, displaying IC50 values roughly in the range of 10-60 µM. Structure-activity relationship study revealed that bulky, hydrophobic, and electron withdrawing substituents at the para-position of the quinazolinone 3-phenyl ring as well as methoxy substitution on the central benzene ring, enhance cytotoxic activity. The four most cytotoxic compounds namely, 45, 43, 47, and 37 were further tested against two human leukemia cell lines namely, HL-60 and K-562 and showed cytotoxic activity in the low micromolar range with compound 45 being the most active, having IC50 values of 1.2 and 1.5 μM, respectively. Interestingly, all four compounds were devoid of cytotoxicity against normal human fibroblasts strain AG01523, indicating that the synthesized rhodanines may be selectively toxic against cancer cells. Mechanistic studies revealed that the most cytotoxic target compounds exhibit pro-apoptotic activity and trigger oxidative stress in cancer cells.

Design and synthesis of unsymmetric benzils, quinoxalines, and evaluations of their anticancer activities against human non‐small lung cancer cells

Synthesis of quinoxalines and assessment of their inhibitory effects against human non-small-cell lung cancer cells

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Synthesis and Cytotoxic Activity of 3-Phenyl-2-thio-quinoxaline 1,4-Dioxide Derivatives in Hypoxia and in Normoxia.

Synthesis and Biological Evaluation of 3-Aryl-quinoxaline-2-carbonitrile 1,4-Di-<em>N</em>-oxide Derivatives as Hypoxic Selective Anti-tumor Agents

Synthesis and Anticancer Evaluation of 4-Anilinoquinolinylchalcone Derivatives

Synthesis of Substituted Benzylamino‐ and Heterocyclylmethylamino Carbodithioate Derivatives of 4‐(3h)‐quinazolinone and Their Cytotoxic Activity.

The Effective Synthesis of New Benzoquinoline Derivatives as Small Molecules with Anticancer Activity

Novel Penta-1,4-Diene-3-One Derivatives Containing Quinazoline And Oxime Ether Fragments: Design, Synthesis And Bioactivity

Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1h-benzo[d]imidazol-2(3h)-one Derivatives.

Facile synthesis and anti-proliferative activity evaluation of quinoxaline derivatives

Design, synthesis, and biological antitumor evaluation of tetrahydroisoquinoline derivatives

Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents.

Design, synthesis, antioxidant and antitumor activity of some 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one-resveratrol hybrids

Synthesis and anticancer activity of novel quinazolinone-based rhodanines

Design, Synthesis and Anti‐Cancer Evaluation of Quinoline‐1,2,4‐triazine Hybrids

Syntheses and Cytotoxicities of Quinazolinone-Based Conjugates

Design, Synthesis, and Antitumor Activity of Β-Carboline- Benzimidazole Hybrids

Design, synthesis and antitumor activity of triphenylphosphonium-linked derivatives of quinazolinone